131 related articles for article (PubMed ID: 34905623)
1. Metabolic syndrome and prostate cancer in Afro-Caribbean men.
Lefebvre F; Blanchet-Deverly A; Michineau L; Blanchet P; Multigner L; Brureau L
Prostate; 2022 Feb; 82(3):359-365. PubMed ID: 34905623
[TBL] [Abstract][Full Text] [Related]
2. Predictors of biochemical recurrence after radical prostatectomy in an Afro-Caribbean population in Guadeloupe (French West Indies).
Brureau L; Emeville E; Multigner L; Blanchet P
Prog Urol; 2018 Jun; 28(8-9):442-449. PubMed ID: 29789237
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.
Lebdai S; Mathieu R; Leger J; Haillot O; Vincendeau S; Rioux-Leclercq N; Fournier G; Perrouin-Verbe MA; Doucet L; Azzouzi AR; Rigaud J; Renaudin K; Charles T; Bruyere F; Fromont G
Urol Oncol; 2018 Feb; 36(2):80.e17-80.e24. PubMed ID: 29153942
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study.
De Nunzio C; Simone G; Brassetti A; Mastroianni R; Collura D; Muto G; Gallucci M; Tubaro A
BMC Cancer; 2016 Jul; 16():407. PubMed ID: 27386844
[TBL] [Abstract][Full Text] [Related]
5. Role of Metabolic Syndrome on Perioperative and Oncological Outcomes at Radical Prostatectomy in a Low-risk Prostate Cancer Cohort Potentially Eligible for Active Surveillance.
Colicchia M; Morlacco A; Rangel LJ; Carlson RE; Dal Moro F; Karnes RJ
Eur Urol Focus; 2019 May; 5(3):425-432. PubMed ID: 29306730
[TBL] [Abstract][Full Text] [Related]
6. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
[TBL] [Abstract][Full Text] [Related]
7. Influence of K656N Polymorphism of the Leptin Receptor Gene on Obesity-Related Traits in Nondiabetic Afro-Caribbean Individuals.
Foucan L; Bassien-Capsa V; Rambhojan C; Lacorte JM; Larifla L
Metab Syndr Relat Disord; 2019 May; 17(4):197-203. PubMed ID: 30807250
[No Abstract] [Full Text] [Related]
8. Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy.
Asmar R; Beebe-Dimmer JL; Korgavkar K; Keele GR; Cooney KA
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):62-6. PubMed ID: 22907512
[TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome is associated with more aggressive prostate cancer.
Ozbek E; Otunctemur A; Dursun M; Sahin S; Besiroglu H; Koklu I; Erkoc M; Danis E; Bozkurt M
Asian Pac J Cancer Prev; 2014; 15(9):4029-32. PubMed ID: 24935591
[TBL] [Abstract][Full Text] [Related]
10. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
[TBL] [Abstract][Full Text] [Related]
11. The effect of metabolic syndrome on prostate cancer final pathology.
Caliskan S; Kaba S; Özsoy E; Keleş MO; Koca O; Akyüz M; Karaman MI
J Cancer Res Ther; 2019 Mar; 15(Supplement):S47-S50. PubMed ID: 30900620
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome increases the risk of upgrading and upstaging in patients with prostate cancer on biopsy: a radical prostatectomy multicenter cohort study.
De Nunzio C; Brassetti A; Simone G; Lombardo R; Mastroianni R; Collura D; Muto G; Gallucci M; Tubaro A
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):438-445. PubMed ID: 29867154
[TBL] [Abstract][Full Text] [Related]
13. Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men.
Zhang X; Zeng X; Liu Y; Dong L; Zhao X; Qu X
Urol Int; 2014; 93(2):214-9. PubMed ID: 24862628
[TBL] [Abstract][Full Text] [Related]
14. The Differential Impact of Body Mass Index and the Feature of Metabolic Syndrome on Oncological Outcomes Following Different Surgical Procedures in Japanese Men with Prostate Cancer.
Shiota M; Takeuchi A; Sugimoto M; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Yokomizo A; Eto M
Ann Surg Oncol; 2017 May; 24(5):1443-1450. PubMed ID: 27896516
[TBL] [Abstract][Full Text] [Related]
15. Impact of metabolic syndrome on oncologic outcomes at radical prostatectomy.
Morlacco A; Dal Moro F; Rangel LJ; Carlson RE; Schulte PJ; Jeffrey KR
Urol Oncol; 2018 Dec; 36(12):528.e1-528.e6. PubMed ID: 30446466
[TBL] [Abstract][Full Text] [Related]
16. Active surveillance in prostate cancer is possible for Afro-Caribbean population: Comparison of oncological outcomes with a Caucasian cohort.
Percot M; Robert G; Bladou F; Ferrière JM; Bensadoun H; Bernhard JC; Alezra E; Capon G; Sénéchal C; Gourtaud G; Brureau L; Roux V; Blanchet P; Eyraud R
Prog Urol; 2020 Sep; 30(10):532-540. PubMed ID: 32593527
[TBL] [Abstract][Full Text] [Related]
17. Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer.
Léon P; Seisen T; Cussenot O; Drouin SJ; Cattarino S; Compérat E; Renard-Penna R; Mozer P; Bitker MO; Rouprêt M
Urol Oncol; 2015 Sep; 33(9):384.e21-7. PubMed ID: 25595576
[TBL] [Abstract][Full Text] [Related]
18. Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican men.
Salgado-Montilla J; Soto Salgado M; Surillo Trautmann B; Sánchez-Ortiz R; Irizarry-Ramírez M
Lipids Health Dis; 2015 Sep; 14():111. PubMed ID: 26377420
[TBL] [Abstract][Full Text] [Related]
19. Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression.
Schiffmann J; Salomon G; Tilki D; Budäus L; Karakiewicz PI; Leyh-Bannurah SR; Pompe RS; Haese A; Heinzer H; Huland H; Graefen M; Tennstedt P
Urol Oncol; 2017 May; 35(5):243-249. PubMed ID: 28161322
[TBL] [Abstract][Full Text] [Related]
20. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.
Freedland SJ; Aronson WJ; Kane CJ; Presti JC; Amling CL; Elashoff D; Terris MK
J Clin Oncol; 2004 Feb; 22(3):446-53. PubMed ID: 14691122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
